NextGen Customer Engagement Platform: Empowering Digital Transformation in the Pharmaceutical Industry
On November 6th, AstraZeneca, Tencent Health, and Accenture jointly announced the launch of the NextGen Customer Engagement Platform at the 6th China International Import Expo. This collaboration aims to assist AstraZeneca China in creating a future-oriented GoToMarket business model, integrating customer management and engagement through an innovative platform ecosystem.
AstraZeneca, a globally renowned biopharmaceutical company driven by innovation, has been operating in the Chinese market for 30 years. In this new phase of development, AstraZeneca prioritizes patient-centric approaches and leverages technology to explore the possibilities of digital healthcare. Together with its partners, the company aims to enhance integrated diagnosis and treatment solutions, enable comprehensive care management, and introduce fresh perspectives to chronic disease management, primary healthcare, and multi-scenario medical services.
The NextGen Customer Engagement Platform:
The NextGen Customer Engagement Platform emerges in this context. This collaboration revolves around three core concepts: an integrated user experience centered around healthcare professionals (HCPs), data-driven business decision-making, and the establishment of a platform ecosystem. The platform aims to support digital healthcare development comprehensively, encompassing communication efficiency, cross-department collaboration, data insights, and intelligent decision-making.
Tencent's Contribution:
Leveraging its leading expertise in artificial intelligence, big data, and cloud computing, Tencent is committed to enhancing efficient communication and collaboration between medical enterprises and healthcare professionals. Tencent Health's Next Generation Engagement Solution (NGES), built on Tencent Cloud's infrastructure, cloud-native architecture, and digital security capabilities, seamlessly integrates IaaS, PaaS, and SaaS layers. The solution incorporates CRM, Events, and MCM tools, providing a cloud-based end-to-end solution for pharmaceutical marketing. With innovation as its driving force, Tencent Health aims to facilitate the healthy and sustainable development of the pharmaceutical industry.
Future Prospects:
Looking ahead, Tencent Health plans to provide comprehensive solutions across the value chain of pharmaceutical enterprises. Through powerful technological advancements and product ecosystems, the company will optimize the allocation and utilization of medical resources. By embracing an open and forward-thinking approach, Tencent Health aims to support the digital transformation of enterprises through continuous exploration and research and development.
The collaboration between AstraZeneca, Tencent Health, and Accenture marks a significant milestone in the digital transformation of the pharmaceutical industry. The NextGen Customer Engagement Platform brings together cutting-edge technologies, data-driven insights, and an innovative ecosystem, empowering AstraZeneca China to create a future-oriented business model and revolutionize customer management and engagement. With Tencent Health's expertise and solutions, the pharmaceutical industry is poised to achieve high-quality and sustainable development in the era of digitalization.
2026-09-08
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Tencent Tang Daosheng: Accelerate the embrace of digital health and activate the endogenous power of the industry
-
Tencent's AI drug discovery platform breaks through the closed-loop capability of high-throughput dry and wet experiments
-
Tencent Cloud officially released two new solutions of intelligent manufacturing
-
U.S. Includes Lithium in National Defense Stockpile for First Time, Plans to Purchase 16,200 Tons Over Five Years
-
Amazon Turns Lilly’s Weight-Loss Pill Into a Retail Logistics Play
-
Vertex Buys Crinetics for $10 Billion: Rare Disease M&A Is Back
-
Nestlé Drops Artificial Colors Worldwide by 2026: Food Additives Face a Reformulation Shock
-
China Keeps Registering Pesticides
-
China’s PE, PP and PVC Exports Rise as Stockpile Releases Reshape Global Supply
-
Panama Canal Tightens Draft Restrictions Again: Chemical Logistics Risk Moves Beyond the Price Sheet
Recommend Reading
-
Global Oil Inventories Fall: Restocking Demand May Keep Petrochemical Costs Supported
-
India Launches Anti-Dumping Probe into PET Film from China, Singapore, Thailand and the UAE
-
Nestlé Drops Artificial Colors Worldwide
-
Rhine Drought Disrupts German Chemical Logistics, Raising Supply Risks for BASF, Covestro and Evonik
-
A Faster Route to Diabetes Drug Chemistry
-
Refrigerant Prices Peak! Domestic Quotas Tighten, U.S. and U.K. Policies Add Fuel to the Fire
-
September Anhydrous Hydrogen Fluoride Market Trend Rises
-
Recent EVA Market Prices Show a Slight Increase
-
Market Conditions Continue to Weaken; Melamine Remains in a Low Range
-
Strong Demand in Peak Season Supports EVA Market Prices in September